ERX Eirx Therap.

RNS Number:3102R
EiRx Therapeutics PLC
01 April 2008


Financial Services Authority




                 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES


1.   Identity of the issuer or the underlying issuer of     Eirx Therapeutics Plc
existing shares to which voting rights are attached:

2.   Reason for notification (please tick the appropriate box or boxes)

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached

An event changing the breakdown of voting rights                            X                 
Other (please specify):                                                     

3.   Full name of person(s) subject to the notification                     Barclays PLC
obligation:

4.   Full name of shareholder(s) (if different from 3):
     Barclays Stockbrokers Ltd

5.   Date of transaction and date on which the threshold is                  19-Mar-08
crossed or reached:

6.   Date on which issuer notified:                                          01-Apr-08

7.   Threshold(s) that is/are crossed or reached:                            13% to 11%

8.   Notified details:






A: Voting rights attached to shares
Class/type of      Situation previous to the   Resulting situation after the triggering transaction
shares             Triggering transaction

                   Number of     Number of     Number of     Number of Voting       % of voting rights
                   Shares        Voting Rights Shares        Rights
If possible use
ISIN code                                                     Direct    Indirect     Direct  Indirect

GB00B0XQBS97       939,660,264   939,660,264   806,354,570   0        806,354,570       0.00     11.56


B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial    Expiration date      Exercise/ conversion No. of voting rights  Percentage of voting
instrument                                period/date          that may be acquired  rights
                                                               (if the instrument
                                                               exercised/converted)


N/A                  N/A                  N/A                  N/A                   N/A


Total (A+B)
Number of voting rights                              Percentage of voting rights
        806,354,570                                             11.56


9.   Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable:
Barclays Stockbrokers Ltd


Proxy Voting:

10. Name of proxy holder:                            N/A

11. Number of voting rights proxy holder will cease  N/A
to hold:

12. Date on which proxy holder will cease to hold    N/A
voting rights:


13. Additional information:                            N/A

14.    Contact name:                                   Geoff Smith

15.    Contact telephone number                        020 7116 2913



For notes on how to complete form TR-1 please see the FSA website.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLUAOURWWRSRAR

Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From May 2024 to Jun 2024

Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Jun 2023 to Jun 2024